Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,487 | 442 | 99.4% |
| Education | $42.00 | 2 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $1,864 | 98 | $0 (2024) |
| Collegium Pharmaceutical, Inc. | $1,132 | 61 | $0 (2024) |
| ABBVIE INC. | $1,048 | 81 | $0 (2024) |
| Azurity Pharmaceuticals, Inc. | $394.93 | 23 | $0 (2024) |
| PFIZER INC. | $329.56 | 27 | $0 (2024) |
| IDORSIA PHARMACEUTICALS US INC | $325.40 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $309.55 | 18 | $0 (2023) |
| Arbor Pharmaceuticals, Inc. | $228.83 | 12 | $0 (2022) |
| RedHill Biopharma Inc. | $193.19 | 13 | $0 (2022) |
| Biohaven Pharmaceuticals, Inc. | $185.12 | 14 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,433 | 86 | Collegium Pharmaceutical, Inc. ($292.02) |
| 2023 | $1,935 | 114 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($503.06) |
| 2022 | $2,151 | 118 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($762.25) |
| 2021 | $2,010 | 126 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($427.50) |
All Payment Transactions
444 individual payment records from CMS Open Payments — Page 1 of 18
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $6.50 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/17/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $14.15 | General |
| Category: Opioid Analgesic | ||||||
| 12/10/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $8.83 | General |
| Category: PAIN | ||||||
| 12/04/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.45 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 12/02/2024 | Virtus Pharmaceuticals LLC | LEVORPHANOL TARTRATE (Drug) | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: ANALGESICS - OPIOID | ||||||
| 11/20/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $18.66 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/12/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $31.76 | General |
| Category: NEUROSCIENCE | ||||||
| 11/07/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $16.49 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 11/06/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $16.45 | General |
| Category: Insomnia | ||||||
| 11/04/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $16.17 | General |
| Category: Opioid Analgesic | ||||||
| 10/30/2024 | VERTEX PHARMACEUTICALS INCORPORATED | — | Food and Beverage | In-kind items and services | $26.48 | General |
| 10/23/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.01 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/23/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $0.55 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 10/22/2024 | Abbott Laboratories | ETERNA (Device) | Food and Beverage | In-kind items and services | $24.83 | General |
| Category: Neuromodulation | ||||||
| 10/15/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $5.99 | General |
| Category: NEUROSCIENCE | ||||||
| 10/14/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.98 | General |
| Category: Opioid Analgesic | ||||||
| 10/07/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $23.89 | General |
| Category: PAIN | ||||||
| 10/01/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/30/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $19.90 | General |
| Category: Opioid Analgesic | ||||||
| 09/24/2024 | SCILEX PHARMACEUTICALS INC. | ZTLido (Drug) | Food and Beverage | In-kind items and services | $21.70 | General |
| Category: Analgesic | ||||||
| 09/17/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $21.82 | General |
| Category: NEUROSCIENCE | ||||||
| 09/16/2024 | Azurity Pharmaceuticals, Inc. | HORIZANT (Drug) | Food and Beverage | In-kind items and services | $20.75 | General |
| Category: CEREBROVASCULARCNS | ||||||
| 09/11/2024 | IDORSIA PHARMACEUTICALS US INC | QUVIVIQ (Drug) | Food and Beverage | In-kind items and services | $13.75 | General |
| Category: Insomnia | ||||||
| 09/10/2024 | Collegium Pharmaceutical, Inc. | XTAMPZA (Drug) | Food and Beverage | Cash or cash equivalent | $23.98 | General |
| Category: Opioid Analgesic | ||||||
| 09/09/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $34.44 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 870 | 4,209 | $600,600 | $206,404 |
| 2022 | 8 | 534 | 2,665 | $254,899 | $77,623 |
| 2021 | 12 | 524 | 1,830 | $256,468 | $92,825 |
| 2020 | 6 | 208 | 805 | $145,381 | $50,740 |
All Medicare Procedures & Services
39 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0482 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 112 | 398 | $186,250 | $77,518 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 150 | 910 | $187,460 | $68,601 | 36.6% |
| 80307 | Testing for presence of drug, by chemistry analyzers | Office | 2023 | 136 | 633 | $126,600 | $38,080 | 30.1% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2023 | 29 | 130 | $15,600 | $4,323 | 27.7% |
| G0481 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 16 | 32 | $10,800 | $4,320 | 40.0% |
| G0480 | Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms | Office | 2023 | 24 | 30 | $8,400 | $3,252 | 38.7% |
| 90791 | Psychiatric diagnostic evaluation | Office | 2023 | 27 | 27 | $5,400 | $3,076 | 57.0% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2023 | 151 | 875 | $21,875 | $2,718 | 12.4% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Office | 2023 | 18 | 18 | $7,200 | $1,630 | 22.6% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2023 | 151 | 874 | $21,850 | $1,347 | 6.2% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 11 | 23 | $3,250 | $947.82 | 29.2% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 18 | 58 | $2,900 | $511.77 | 17.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 27 | 201 | $3,015 | $77.75 | 2.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 126 | 860 | $177,129 | $63,672 | 35.9% |
| 20553 | Injection of trigger points, 3 or more muscles | Office | 2022 | 36 | 149 | $17,880 | $5,474 | 30.6% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2022 | 93 | 355 | $24,850 | $4,279 | 17.2% |
| 96127 | Assessment of emotional or behavioral problems | Office | 2022 | 113 | 584 | $14,600 | $1,967 | 13.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2022 | 16 | 26 | $3,500 | $1,058 | 30.2% |
| 96160 | Administration and interpretation of patient-focused health risk assessment | Office | 2022 | 113 | 584 | $14,600 | $971.04 | 6.7% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2022 | 12 | 21 | $1,050 | $163.73 | 15.6% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2022 | 25 | 86 | $1,290 | $38.43 | 3.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 117 | 998 | $205,588 | $80,440 | 39.1% |
| 20553 | Injections of trigger points in 3 or more muscles | Office | 2021 | 33 | 99 | $11,880 | $3,742 | 31.5% |
| 80305 | Testing for presence of drug, read by direct observation | Office | 2021 | 95 | 226 | $15,820 | $2,835 | 17.9% |
| 99205 | New patient outpatient visit, total time 60-74 minutes | Office | 2021 | 12 | 12 | $4,800 | $1,535 | 32.0% |
About Debra Knuckles, N.P
Debra Knuckles, N.P is a Family healthcare provider based in Concord, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 01/30/2007. The National Provider Identifier (NPI) number assigned to this provider is 1679610844.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Debra Knuckles, N.P has received a total of $7,529 in payments from pharmaceutical and medical device companies, with $1,433 received in 2024. These payments were reported across 444 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($7,487).
As a Medicare-enrolled provider, Knuckles has provided services to 2,136 Medicare beneficiaries, totaling 9,509 services with total Medicare billing of $427,591. Data is available for 4 years (2020–2023), covering 39 distinct procedure/service records.
Practice Information
- Specialty Family
- Other Specialties Nurse Practitioner
- Location Concord, NC
- Active Since 01/30/2007
- Last Updated 08/13/2015
- Taxonomy Code 363LF0000X
- Entity Type Individual
- NPI Number 1679610844
Products in Payments
- RELISTOR (Drug) $1,864
- XTAMPZA (Drug) $988.62
- UBRELVY (Drug) $788.68
- NURTEC ODT (Drug) $591.51
- Horizant (Drug) $367.58
- QUVIVIQ (Drug) $325.40
- BELSOMRA (Drug) $309.55
- QULIPTA (Drug) $259.23
- HORIZANT (Drug) $256.18
- Movantik (Drug) $193.19
- ZTLido (Drug) $165.85
- Kloxxado (Drug) $156.52
- Belbuca (Drug) $143.50
- Lucemyra (Drug) $139.92
- Saxenda (Drug) $97.76
- Dayvigo (Drug) $97.25
- PROLATE (Drug) $88.38
- COMIRNATY (Biological) $77.99
- Proclaim IPG (Device) $64.97
- BELBUCA (Drug) $61.18
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Doctors in Concord
Brant Oliver, Np, Msn, Cs, Aprn-Bc, NP, MSN, CS, APRN-BC
Family — Payments: $5,043
Mrs. Melanie Anello, N.p.-C, N.P.-C
Family — Payments: $3,329
Christine Kociszewski, Aprn, APRN
Family — Payments: $3,147
Mr. Richard Heneghan, Rnnp, RNNP
Family — Payments: $2,524
Amy Kennedy, Aprn, APRN
Family — Payments: $1,974
Mrs. Trisha Brooks, Aprn, APRN
Family — Payments: $1,946